$3.82
+0.23 (+6.41%)
VNDA News2 articles
Reviva Pharma Enacts Reverse Split to Fend Off Nasdaq Delisting
Reviva Pharmaceuticals Holdings has implemented a 1-for-20 reverse stock split to boost its share price and avoid a Nasdaq delisting, with a critical compliance deadline of March 27. The company also faces financing challenges for an additional Phase 3 trial of its schizophrenia drug candidate, brilaroxazine.
AT&T Fiber Vandalism Outages Fail to Move Shares; Theft Costs Minimal
AT&T (NYSE:T) shares were unchanged after fiber vandalism caused outages in California and Kentucky. The $76 million annual theft cost is a tiny fraction of cash flow, so investors shrugged off the disruption.